Cowen and Company’s AEON Biopharma, Inc. Warrants, each whole warrant exercisable to purchase one share of Class A Common Stock at an exercise price of $11.50 per share AEON.WS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-231,860
| Closed | -$23.2K | – | 713 |
|
|
2023
Q4 | $23.2K | Sell |
231,860
-100
| -0% | -$10 | ﹤0.01% | 331 |
|
|
2023
Q3 | $34.8K | Sell |
231,960
-75,628
| -25% | -$11.3K | ﹤0.01% | 300 |
|
|
2023
Q2 | $27.7K | Buy |
307,588
+23,400
| +8% | +$2.11K | ﹤0.01% | 300 |
|
|
2023
Q1 | $15.6K | Buy |
284,188
+16,666
| +6% | +$917 | ﹤0.01% | 317 |
|
|
2022
Q4 | $12.2K | Buy |
+267,522
| New | +$12.2K | ﹤0.01% | 343 |
|
|
2021
Q4 | – | Sell |
-20,782
| Closed | -$12K | – | 608 |
|
|
2021
Q3 | $12K | Sell |
20,782
-4,218
| -17% | -$2.44K | ﹤0.01% | 378 |
|
|
2021
Q2 | $25K | Buy |
+25,000
| New | +$25K | ﹤0.01% | 348 |
|